NEC contributes to development of artificial DNA aptamer that binds to the novel coronavirus (SARS-CoV-2) Kumar Jeetendra | May 6, 2021 India, May 6, 2021 – NEC Corporation (NEC; TSE: 6701) and NEC Solution Innovators today announced the successful development of artificial DNA aptamers (*1) that bind to the novel coronavirus (SARS-CoV-2). This breakthrough stems from the NEC Group’s efforts to promote spatial monitoring business using aptamers, including the development of new biosensing systems, such as …
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail used in the treatment of Covid-19 Kumar Jeetendra | May 5, 2021 Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19 Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients Partners with Cipla for pan-India distribution At a global level, Roche and its partner Regeneron are collaborating to …
Researchers grow better approach to screen electrostatic signs radiated by honeybees Kumar Jeetendra | May 5, 2021 Honeybees have a complex communication system. Between buzzes and body movements, they can direct hive mates to food sources, signal danger, and prepare for swarming – all indicators of colony health. And today, researchers are listening in. Scientists based in Germany – with collaborators in China and Norway – have developed a way to monitor …
Critical care attendants in poor physical and mental wellness report more medical errors Kumar Jeetendra | May 4, 2021 A study led by The Ohio State University College of Nursing finds that critical care nurses in poor physical and mental health reported significantly more medical errors than nurses in better health. The analysis, which was conducted prior to the COVID-19 pandemic, also found that”nurses who perceived their worksite was very supportive of the well-being …
Practo aims to vaccinate over one crore Indians as part of ‘Corporate Suraksha’ program Kumar Jeetendra | May 3, 2021 Bengaluru, May 3, 2021: As India battles a deadly second wave of COVID-19 and the need for immunization intensifies, Practo today announced ‘Corporate Suraksha’, a corporate vaccination program for companies across the country. The registrations are now open (https://www.partnership.practo.com/suraksha) for corporates to enlist their employees and their family members for the inoculation. Additionally, corporates can …
Antiviral T cells protected, viable as off-the-shelf treatment for painful complication stem cells Kumar Jeetendra | May 2, 2021 Infusion of T cells targeting BKV resulted in rapid responses, with 67.7% of patients seeing a complete or partial improvement in symptoms after 14 days. This increased to 81.6% of patients after 28 days post-infusion. No cases of grade 3 or grade 4 graft versus host disease (GVHD) or other infusion-related toxicities occurred. Addressing a …
Novel technique gives quicker and more exact diagnostics in histopathology Kumar Jeetendra | May 1, 2021 Histology is the study of biological cells at a microscopic level. Also called microscopic anatomy, histology is widely used to offer identification of cancer and other diseases. For instance, tissue samples obtained during surgery might help to ascertain whether additional surgical action is needed, and additional surgery may be avoided if a diagnosis can be …
New hereditarily encoded sensor recognizes drugs of abuse Kumar Jeetendra | April 29, 2021 A genetically encoded sensor to detect hallucinogenic compounds has been developed by researchers at the University of California, Davis. Named psychLight, the sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse. The work is published April 28 in the journal Cell. Compounds associated with …
J Mitra Launches India’s First Covid-19 Neutralizing Antibody Test Kumar Jeetendra | April 29, 2021 New Delhi, 29th April 2021: J Mitra & Company, the global leader in the IVD space, has launched India’s first Covid-19 Neutralizing Antibody Microlisa Elisa Test its ongoing fight against the corona pandemic. The test kit has cleared all government parameters and received all necessary approvals, including Drug Controller General of India (DCGI) & successful …
Novel platform has potential to detect many disease-related biomarkers in just one test Kumar Jeetendra | April 28, 2021 Most conventional molecular diagnostics usually detect only one disease-related biomarker. Fantastic examples are the PCR tests now used to diagnose COVID-19 by detecting a particular sequence from SARS-CoV-2. Such so-called singleplex methods give reliable results because they are”calibrated” to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 version or …
Researchers examine how oxygen radicals secure against cancer Kumar Jeetendra | April 26, 2021 Initially, oxygen radicals – reactive oxygen species, or ROS for short – were thought of as exclusively harmful in the body. They’re produced, by way of example, by smoking or UV radiation. Because of their high reactivity, they could damage many important molecules in cells, including the hereditary molecule DNA. As a result, there’s a …
Moderna vaccine being surveyed for WHO emergency listing: WHO representative Kumar Jeetendra | April 26, 2021 Moderna’s COVID-19 vaccine is being reviewed on Monday by technical experts for possible WHO emergency use listing, a World Health Organization spokesman told Reuters. “Moderna is being reviewed at the TAG (technical advisory group) meeting today,” WHO spokesman Christian Lindmeier said in reply to a query. A decision on the US drugmaker’s vaccine was expected …
